Harrow, Inc.
HROW
#5478
Rank
HK$10.30 B
Marketcap
HK$276.73
Share price
-0.34%
Change (1 day)
36.58%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2025 (TTM): HK$0.15 Billion

According to Harrow, Inc.'s latest financial reports the company's current earnings are HK$0.25 Billion. In 2024 the company made an earning of HK$42.83 Million, an increase over its 2023 earnings that were of -HK$18.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$0.15 B262.24%
2024 HK$42.83 M-329.09%
2023 -HK$18.7 Million-224.34%
2022 HK$15.03 M3.01%
2021 HK$14.6 M149.06%
2020 HK$5.86 M434.29%
2019 HK$1.09 M-102.68%
2018 -HK$40.89 Million-57.11%
2017 -HK$95.33 Million-21.93%
2016 -HK$0.13 Billion5.11%
2015 -HK$0.12 Billion46.16%
2014 -HK$79.48 Million32.68%
2013 -HK$59.9 Million42.63%
2012 -HK$42 Million
2010 -HK$19.41 Million-45.76%
2009 -HK$35.77 Million21.83%
2008 -HK$29.37 Million-491.97%
2007 HK$7.49 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-HK$1.25 Billion-902.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$0.15 Billion-191.39%๐Ÿ‡บ๐Ÿ‡ธ USA